Gavin Liu, MD, PhD, is Director of Business Development at Deep Intelligent Pharma (DIP), an AI-powered clinical research organization. He brings extensive experience across biomedical research, cell and gene therapy, clinical development, and global regulatory strategy.
With nearly a decade of experience in cell and gene therapy, including CAR-T, CAR-NK, and iPSC-based therapies, Gavin has worked across scientific, clinical, and business development functions. At DIP, he focuses on helping biotech and pharmaceutical companies advance global clinical programs through AI-enabled clinical development, regulatory and medical writing, and clinical operations across the U.S., China, and Japan.